(Q44657559)
Statements
1 reference
A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression (English)
1 reference
A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin .BETA.1 Expression (English)
1 reference
1 reference
1 reference
Nan Jia
1 reference
Hiroshi Okamoto
1 reference
Toshihiro Shimizu
1 reference
Satoru Chiba
1 reference
Yutaka Matsui
1 reference
Takeshi Sugawara
1 reference
Masatoshi Akino
1 reference
Akira Kitabatake
1 reference
1 September 2003
1 reference
1 reference
26
1 reference
9
1 reference
737-742
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference